Assessing Attitudes and Participation Regarding a Pilot COVID-19 Workplace Vaccination Program in Southern Germany Considering the Occupational Health Perspective-A Mixed Methods Study.
COVID-19 vaccination
COVID-19 vaccination campaign
Germany
employees
mixed methods research
occupational health services
occupational medicine
qualitative research
quantitative research
vaccination in workplace settings
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
09 Jun 2023
09 Jun 2023
Historique:
received:
09
05
2023
revised:
07
06
2023
accepted:
08
06
2023
medline:
28
6
2023
pubmed:
28
6
2023
entrez:
28
6
2023
Statut:
epublish
Résumé
This mixed methods study retrospectively assessed attitudes and participation of employees, occupational health personnel, and key personnel regarding the rollout of a pilot COVID-19 workplace vaccination program in five German companies in May/June 2021 in Baden-Württemberg (Southern Germany) by combining survey data and qualitative interviews. A total of 652 employees completed a standardized questionnaire and we conducted ten interviews with occupational health personnel and key personnel with other professional backgrounds organizing the pilot workplace vaccination program. Survey data were analyzed descriptively and interviews were audio recorded, transcribed verbatim, and analyzed using qualitative content analysis. Employees participated widely in COVID-19 vaccinations at their workplaces, and most employees (n = 608; 93.8%) had a full COVID-19 immunization at the time of the survey. The main advantages of the pilot COVID-19 workplace vaccination program were seen in the flexible and time-saving vaccination offer as well as the trust in and long-standing relationship with occupational health physicians. The main disadvantage of the pilot vaccination offer was increased workload for occupational health personnel, especially during the roll-out phase of the program. The pilot COVID-19 workplace vaccination program was predominantly positively assessed, and the important role of occupational health services in managing the COVID-19 pandemic was highlighted. The main criticisms of the COVID-19 workplace vaccination program related to the high organizational and administrative burden. Findings from our study can support the development of future programs for the administration of generally recommended vaccination in the workplace setting in Germany.
Identifiants
pubmed: 37376471
pii: vaccines11061082
doi: 10.3390/vaccines11061082
pmc: PMC10304481
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Ministry of Science, Research, and Art in Baden-Wurttemberg
ID : 42-5400/136/1
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest. J.S.-K.’s sole permanent employment relationship is with the Landkreis Reutlingen (public health department). She declares no conflict of interest.
Références
Occup Med (Lond). 2022 May 23;72(4):235-237
pubmed: 34551113
Int J Environ Res Public Health. 2022 Aug 04;19(15):
pubmed: 35954960
J Public Health (Oxf). 2021 Sep 22;43(3):e462-e481
pubmed: 33855434
BMC Public Health. 2015 Apr 09;15:343
pubmed: 25886159
Vaccines (Basel). 2022 Aug 30;10(9):
pubmed: 36146511
Lancet. 2022 Mar 5;399(10328):924-944
pubmed: 35202601
Lancet Infect Dis. 2022 Sep;22(9):e254-e266
pubmed: 35429463
Fam Pract. 2023 Mar 28;40(2):369-376
pubmed: 36242538
J Health Serv Res Policy. 2008 Apr;13(2):92-8
pubmed: 18416914
Med Care. 2013 Aug;51(8):e51-7
pubmed: 23860333
PLoS One. 2018 Dec 7;13(12):e0208601
pubmed: 30532274
Health Psychol. 2023 Mar;42(3):205-212
pubmed: 36066859
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2004 Dec;47(12):1204-15
pubmed: 15583892
Med Lav. 2022 Apr 26;113(2):e2022018
pubmed: 35481577
Vaccines (Basel). 2022 Aug 18;10(8):
pubmed: 36016238
Gesundheitswesen. 2023 May 30;:
pubmed: 37253371
Hum Vaccin Immunother. 2022 Dec 31;18(1):2027160
pubmed: 35113777
Int J Environ Res Public Health. 2022 Dec 29;20(1):
pubmed: 36612934
BMJ. 2021 Sep 30;374:n2061
pubmed: 34593508
Vaccines (Basel). 2023 Mar 13;11(3):
pubmed: 36992225
Postgrad Med J. 2022 Oct 1;98(1164):756-764
pubmed: 37062994
Fam Pract. 2022 Oct 21;:
pubmed: 36269200
BMJ Open. 2020 Nov 18;10(11):e043908
pubmed: 33208339
Int J Environ Res Public Health. 2021 Oct 31;18(21):
pubmed: 34769990
Int J Environ Res Public Health. 2021 Oct 19;18(20):
pubmed: 34682748